The cytokine erythropoietin (EPO) possesses potent neuroprotective activity against a
variety of potential brain injuries, including transient ischemia and reperfusion. It is currently …

… used at a concentration of 100 nm by adding the stimulus directly into the culture medium. …
animals 3 d after MCAO were stimulated with 1 μm CpG-ODN overnight, and IL12p40 and TNF…

The physiological effects of pineal melatonin are primarily mediated by melatonin receptors
located in the brain and periphery. Even though there are a number of studies demonstrating …

Erythropoietin (Epo) prevents ischemia and hypoxia-induced neuronal death in vitro. Recent
studies have shown that this cytokine also has in vivo neuroprotective effects in cerebral …

Long-term drug-induced alterations in CNS gene expression may be responsible for some
therapeutic effects, such as antidepressant action, as well as for psychopathological …

Recently, we have reported that erythropoietin (Epo) provides neuroprotection in 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine
(MPTP)-induced neurotoxicity in vivo. In the present study…

Sensitization to psychostimulants can be influenced by circadian rhythms. The pineal gland,
the main source of circadian melatonin synthesis, may influence behavioral sensitization to …

Erythropoietin (EPO), produced by the kidney and fetal liver, is a cytokine-hormone that
stimulates erythropoiesis under hypoxic conditions. It has been shown that EPO is produced in …

Hypoxic–ischemic encephalopathy seen in survivors of perinatal asphyxia is a frequently
encountered and a major clinical problem for which there is currently no effective treatment. …

… The vaccine is assumed to lead to VEGFR-2 protein expression in monocytes and dendritic
cells after entry of VXM01 in the Peyer’s patches via M cells of the gut, and internalization by …